Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GDRX
GDRX logo

GDRX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GDRX News

GoodRx Q1 2026 Earnings Call Highlights

2d agoseekingalpha

GoodRx Q1 Earnings Beat Expectations Amid Revenue Decline

3d agoseekingalpha

GoodRx Launches Oral Ozempic® Treatment for Diabetes

May 01 2026Newsfilter

GOODRX HOLDINGS INC - INCREASES AVAILABILITY OF OZEMPIC PILL STARTING AT $149 PER MONTH

May 01 2026moomoo

GoodRx Launches FDA-Approved Foundayo Medication for Weight Management

Apr 09 2026Newsfilter

GoodRx Stock Jumps 5.1% in Premarket Trading Following Announcement of Self-Pay Access to Eli Lilly's New Weight-Loss Medication

Apr 09 2026moomoo

GOODRX INCREASES AVAILABILITY OF ELI LILLY'S NEW ORAL GLP-1, FOUNDAYO™, AND ZEPBOUND® KWIKPEN® WITH SELF-PAY PRICING AT OVER 70,000 PHARMACIES ACROSS THE COUNTRY

Apr 09 2026moomoo

GoodRx Partners with Viatris to Offer Up to 85% Discounts on Medications

Mar 11 2026seekingalpha

GDRX Events

05/06 17:10
GoodRx Q1 Revenue $194M Beats Expectations
Reports Q1 revenue $194M, consensus $185.12M. "We delivered a strong start to the year, with continued momentum across our strategic growth priorities," said Wendy Barnes, President and Chief Executive Officer of GoodRx. "Our results demonstrate that the strategy we laid out last quarter is working and that we are building a sustainable value proposition. We believe that momentum is driving durable growth and increasing value for consumers and our partners."
05/06 17:10
Raises FY26 Adjusted EBITDA Outlook to Over $235M
Consensus $764.78M. Raises FY26 adjusted EBITDA view to over $235M from over $230M.
05/06 14:50
Notable Companies Earnings Consensus: Arm 58c, AppLovin $3.64
Notable companies reporting after the market close, with earnings consensus, include Arm (ARM), consensus 58c... AppLovin (APP), consensus $3.64... DoorDash (DASH), consensus $1.07... Warner Bros. Discovery (WBD), consensus (10c)... Coherent (COHR), consensus $1.39... Fortinet (FTNT), consensus 62c... Snap (SNAP), consensus 10c... Zillow (ZG), consensus 46c... Paycom (PAYC), consensus $2.99... GoodRX (GDRX), consensus 7c.

GDRX Monitor News

No data

No data

GDRX Earnings Analysis

No Data

No Data

People Also Watch